Screening Assay for the Identification of Deoxyhypusine Synthase Inhibitors

Abstract

The 1st step in the posttranslational hypusine [N^ε-(4-amino-2-hydroxybutyl)lysine] modification of eukaryotic translation initiation factor 5A (eIF5A) is catalyzed by deoxyhypusine synthase (DHS). The eIF5A intermediate is subsequently hydroxylated by deoxyhypusine hydroxylase (DHH), thereby converting the eIF5A precursor into a biologically active protein. Depletion of eIF5A causes inhibition of cell growth, and the identification of eIF5A as a cofactor of the HIV Rev protein turns this host protein and therefore DHS into an interesting target for drugs against abnormal cell growth and/or HIV replication. The authors developed a 96-well format DHS assay applicable for the screening of DHS inhibitors. Using this assay, they demonstrate DHS inhibition by AXD455 (Semapimod, CNI-1493). This assay represents a powerful tool for the identification of new DHS inhibitors with potency against cancer and HIV.

Keywords

DHS eIF5A spermidine 96-well HIV

References

1. Kang HA , Hershey JW : Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 1994;269:3934-3940.

2. Bevec D , Jaksche H , Oft M , Wohl T , Himmelspach M , Pacher A , et al : Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 1996;271:1858-1860.

3. Park MH , Wolff EC , Folk JE : Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci 1993;18:475-479.

4. Park MH , Wolff EC , Folk JE : Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 1993;4:95-104.

5. Park MH , Joe YA , Kang KR : Deoxyhypusine synthase activity is essential for cell viability in the yeast Saccharomyces cerevisiae. J Biol Chem 1998;273:1677-1683.

6. Lee Y , Kim HK , Park HE , Park MH , Joe YA : Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis. Mol Cell Biochem 2002;237:69-76.

7. Lipowsky G , Bischoff FR , Schwarzmaier P , et al : Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 2000;19:4362-4371.

8. Rosorius O , Reichart B , Kratzer F , Heger P , Dabauvalle MC , Hauber J : Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1. J Cell Sci 1999;112(Pt 14):2369-2380.

9. Ruhl M , Himmelspach M , Bahr GM , Hammerschmid F , Jaksche H , Wolff B , et al : Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol 1993;123:1309-1320.

10.

10. Elfgang C , Rosorius O , Hofer L , Jaksche H , Hauber J , Bevec D : Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals. Proc Natl Acad Sci U S A 1999;96:6229-6234.

11.

11. Hofmann W , Reichart B , Ewald A , Muller E , Schmitt I , Stauber RH , et al : Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol 2001;152:895-910.

12.

12. Pollard VW , Malim MH : The HIV-1 Rev protein. Annu Rev Microbiol 1998;52:491-532.

13.

13. Junker U , Bevec D , Barske C , Kalfoglou C , Escaich S , Dobrovnik M , et al : Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study. Hum Gene Ther 1996;7:1861-1869.

14.

14. Chen G , Gharib TG , Thomas DG , Huang CC , Misek DE , Kuick RD , et al : Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics 2003;3:496-504.

15.

15. Bevec D , Kappel B , Jaksche H , Csonga R , Hauber J , Klier H , et al : Molecular characterization of a cDNA encoding functional human deoxyhypusine synthase and chromosomal mapping of the corresponding gene locus. FEBS Lett 1996;378:195-198.

16.

16. Brenner BG , Turner D , Wainberg MA : HIV-1 drug resistance: can we overcome? Expert Opin Biol Ther 2002;2:751-761.

17.

17. Menendez-Arias L : Targeting HIV : antiretroviral therapy and development of drug resistance. Trends Pharmacol Sci 2002;23:381-388.